Joseph Damond

Joe works with leading clients in the health care industry to advance health policy initiatives and navigate the evolving global political and regulatory landscape. He also focuses on the international trade and investment challenges facing multinational companies. As a recognized leader on issues of emerging technologies, Joe uses his three decades of experience to provide insight on standards, best practices, legislation, regulation, and public preparedness.

Prior to joining CMI, Joe was the Chair of Health Policy at Edelman Global Advisory. Joe also served as Deputy Chief Policy Officer and Executive Vice President for International Affairs at the Biotechnology Innovation Organization (BIO), where he developed the industry association’s global policy strategy on healthcare, economic and trade issues, and foreign government relations policy. Before his work at BIO, Joe served as Vice President for International Government Relations for Pfizer, where he managed their international trade and commercial issues, including leading industry efforts to strengthen market access and intellectual property (IP) provisions in the U.S.-Korea Free Trade Agreement. Prior to Pfizer, he worked as Deputy Vice President for International Affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA) where he led Asia and global market access programs, and developed the industry’s successful strategy for market IP and access provisions in the U.S.-Australia Free Trade Agreement.

Joe spent more than ten years at the Office of the U.S. Trade Representative, serving in several capacities, including Special Economic Assistant to the U.S. Trade Representative (USTR), Executive Director of the Generalized System of Preferences, and Deputy Assistant USTR for Asia and Pacific.

Joe studied at Princeton and Georgetown universities, and authored the book, Give Trade a Chance: The Negotiation of the U.S.-Vietnam Bilateral Trade Agreement.